Publication Name	World Journal of Cardiology
Manuscript ID	90383
Country	India

Received	2023-12-01 17:02
Peer-Review Started	2023-12-01 17:02
To Make the First Decision
Return for Revision	2024-02-05 06:21
Revised	2024-02-12 07:28
Second Decision	2024-03-26 01:21
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-03-26 02:49
Articles in Press	2024-03-26 02:49
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-04-11 02:01
Publish the Manuscript Online	2024-04-23 08:34

ISSN	1949-8462 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Editorial
Article Title	Transcatheter aortic valve replacement in low-risk young population: A double edge sword?
Manuscript Source	Invited Manuscript
All Author List	Sukhdeep Bhogal and Akash Batta
ORCID	Author(s) ORCID Number Sukhdeep Bhogal http://orcid.org/0000-0001-9212-557X Akash Batta http://orcid.org/0000-0002-7606-5826
Funding Agency and Grant Number
Corresponding Author	Akash Batta, Doctor, MD, Assistant Professor, Researcher, Department of Cardiology, Dayanand Medical College and Hospital, Tagore Nagar, Civil Lines, Ludhiana 141001, India. akashbatta02@gmail.com
Key Words	Transcatheter aortic valve replacement; Surgical aortic valve replacement; Pacemaker implantation; Coronary re-access; Structural deterioration
Core Tip	In 2019, the United States Food and Drug Administration approved transcatheter aortic valve replacement (TAVR) in low-risk patients based on the two large randomized trials. However, patients with certain unfavorable anatomies and clinical profiles were excluded from these trials. Despite the lack of clear evidence in young patients (< 65 years), it may be preferred by this population given the benefits of early discharge, shorter hospital stay, and expedite recovery. Nonetheless, it is important to ruminate various factors including lifetime expectancy, risk of pacemaker implantation, and the need for future valve or coronary interventions in young cohorts before considering TAVR in these patients.
Publish Date	2024-04-23 08:34
Citation	Bhogal S, Batta A. Transcatheter aortic valve replacement in low-risk young population: A double edge sword? World J Cardiol 2024; 16(4): 177-180
URL	https://www.wjgnet.com/1949-8462/full/v16/i4/177.htm
DOI	https://dx.doi.org/10.4330/wjc.v16.i4.177

Full Article (PDF)	WJC-16-177-with-cover.pdf
Manuscript File	90383_Auto_Edited-YJP.docx
Answering Reviewers	90383-Answering reviewers.pdf
Audio Core Tip	90383-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	90383-Conflict-of-interest statement.pdf
Copyright License Agreement	90383-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	90383-Language certificate.pdf
Peer-review Report	90383-Peer-review(s).pdf
Scientific Editor Work List	90383-Scientific editor work list.pdf
CrossCheck Report	90383-CrossCheck repot.pdf